IL323075A - Phenylalkylamine drugs - Google Patents
Phenylalkylamine drugsInfo
- Publication number
- IL323075A IL323075A IL323075A IL32307525A IL323075A IL 323075 A IL323075 A IL 323075A IL 323075 A IL323075 A IL 323075A IL 32307525 A IL32307525 A IL 32307525A IL 323075 A IL323075 A IL 323075A
- Authority
- IL
- Israel
- Prior art keywords
- compound
- stereoisomer
- solvate
- hydrate
- pharmaceutically acceptable
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363449511P | 2023-03-02 | 2023-03-02 | |
| US202363468956P | 2023-05-25 | 2023-05-25 | |
| PCT/US2024/018413 WO2024182807A2 (en) | 2023-03-02 | 2024-03-04 | Phenylalkylamine prodrugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL323075A true IL323075A (en) | 2025-10-01 |
Family
ID=92590513
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL323075A IL323075A (en) | 2023-03-02 | 2024-03-04 | Phenylalkylamine drugs |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP4673430A2 (de) |
| JP (1) | JP2026508371A (de) |
| CN (1) | CN121127458A (de) |
| IL (1) | IL323075A (de) |
| WO (1) | WO2024182807A2 (de) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3288946T3 (da) * | 2015-04-27 | 2019-11-25 | Arena Pharm Inc | 5-ht2c-receptoragonister og sammensætninger og anvendelsesfremgangsmåder |
-
2024
- 2024-03-04 CN CN202480029191.6A patent/CN121127458A/zh active Pending
- 2024-03-04 JP JP2025551034A patent/JP2026508371A/ja active Pending
- 2024-03-04 IL IL323075A patent/IL323075A/en unknown
- 2024-03-04 EP EP24764717.5A patent/EP4673430A2/de active Pending
- 2024-03-04 WO PCT/US2024/018413 patent/WO2024182807A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP2026508371A (ja) | 2026-03-10 |
| EP4673430A2 (de) | 2026-01-07 |
| WO2024182807A3 (en) | 2024-11-14 |
| CN121127458A (zh) | 2025-12-12 |
| WO2024182807A2 (en) | 2024-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12465578B2 (en) | Substituted alpha-ethyl phenylalkylamines | |
| US20250195471A1 (en) | Asymmetric allyl tryptamines | |
| US12221428B2 (en) | Use of deuterated empathogens as therapeutic agents | |
| IL323075A (en) | Phenylalkylamine drugs | |
| WO2024243599A1 (en) | Asymmetric phenylalkylamines | |
| EP4673127A1 (de) | Deuterierte und fluorierte empathogene | |
| US12180176B2 (en) | Fluorinated empathogens | |
| US20250248969A1 (en) | Combinations of monoamine oxidase inhibitors and serotonin receptor agonists and their therapeutic use | |
| WO2024091523A1 (en) | Conformationally restricted phenethylamine analogs | |
| AU2024225907A1 (en) | Hydroxyalkyl and methoxyalkyl tryptamines | |
| WO2025137730A1 (en) | N-substituted tryptamines and n-substituted lysergamides and their use as therapeutic agents |